Nabumetone 750 MG Oral Tablet — RxCUI 311893
RxNorm drug concept · Semantic clinical drug
RxCUI 311893
Semantic clinical drug · SCD
● Current RxNorm concept 38 FDA products
102 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311893
Official nameNabumetone 750 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped38
Package NDCs mapped102
Reported Medicaid activity (SDUD)240,684 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Nabumetone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Nabumetone is a prescription anti-inflammatory medication used to ease the pain, swelling, and stiffness that come with osteoarthritis and rheumatoid arthritis. It won't cure arthr...
- Yes, you can take it with or without food — both are fine. Taking it with food or milk does speed up how quickly it gets into your system, so if you want faster relief, with a meal...
- Can I take nabumetone with food? Does it matter?
- The most common ones are digestive — things like diarrhea, indigestion, and stomach pain. Those are bothersome but usually manageable. What you really want to watch out for are bla...
🕸️ Concept Web — How Nabumetone 750 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Nabumetone 750 MG Oral Tablet
RxCUI 311893 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Nabumetone
31448IN
-
Nabumetone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Relafen
203754BN
-
Relafen
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nabumetone Oral Tablet
378684SCDF -
Nabumetone Oral Product
1158379SCDG -
Nabumetone Pill
1158380SCDG -
Nabumetone Oral Tablet [Relafen]
368811SBDF -
Relafen Oral Product
1180091SBDG -
Relafen Pill
1180092SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Nabumetone Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Nabumetone 750 MG
343093SCDC -
Nabumetone 750 MG Oral Tablet [Relafen]
206959SBD -
Nabumetone 750 MG [Relafen]
567760SBDC
-
Nabumetone 750 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Nabumetone 750 MG
SCDC · 343093 -
Nabumetone Oral Tablet
SCDF · 378684 -
Nabumetone Oral Product
SCDG · 1158379 -
Nabumetone Pill
SCDG · 1158380
Brand-Name Concepts
-
Nabumetone 750 MG Oral Tablet [Relafen]
SBD · 206959 -
Nabumetone 750 MG [Relafen]
SBDC · 567760 -
Nabumetone Oral Tablet [Relafen]
SBDF · 368811 -
Relafen Oral Product
SBDG · 1180091 -
Relafen Pill
SBDG · 1180092 -
Relafen
BN · 203754
📦 FDA Products & Package NDCs
38 products · 102 package NDCs
102 package NDCs map to RxCUI 311893 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00591-3670-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3670-01) | Nabumetone | Actavis Pharma, Inc. | 2011-06-13 |
| 00591-3670-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3670-05) | Nabumetone | Actavis Pharma, Inc. | 2011-06-13 |
| 00591-3671-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3671-01) | Nabumetone | Actavis Pharma, Inc. | 2011-06-13 |
| 00591-3671-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3671-05) | Nabumetone | Actavis Pharma, Inc. | 2011-06-13 |
| 50090-6167-00 | 30 TABLET in 1 BOTTLE (50090-6167-0) | Nabumetone | A-S Medication Solutions | 2022-10-13 |
| 50090-6167-02 | 14 TABLET in 1 BOTTLE (50090-6167-2) | Nabumetone | A-S Medication Solutions | 2022-10-13 |
| 50090-6167-03 | 60 TABLET in 1 BOTTLE (50090-6167-3) | Nabumetone | A-S Medication Solutions | 2022-10-13 |
| 50090-6167-04 | 20 TABLET in 1 BOTTLE (50090-6167-4) | Nabumetone | A-S Medication Solutions | 2022-10-13 |
| 50228-0465-01 | 100 TABLET in 1 BOTTLE (50228-465-01) | Nabumetone | ScieGen Pharmaceuticals Inc | 2019-06-26 |
| 50228-0465-05 | 500 TABLET in 1 BOTTLE (50228-465-05) | Nabumetone | ScieGen Pharmaceuticals Inc | 2019-06-26 |
| 50228-0465-30 | 30 TABLET in 1 BOTTLE (50228-465-30) | Nabumetone | ScieGen Pharmaceuticals Inc | 2019-06-26 |
| 50228-0466-01 | 100 TABLET in 1 BOTTLE (50228-466-01) | Nabumetone | ScieGen Pharmaceuticals Inc | 2019-06-26 |
| 50228-0466-05 | 500 TABLET in 1 BOTTLE (50228-466-05) | Nabumetone | ScieGen Pharmaceuticals Inc | 2019-06-26 |
| 50228-0466-30 | 30 TABLET in 1 BOTTLE (50228-466-30) | Nabumetone | ScieGen Pharmaceuticals Inc | 2019-06-26 |
| 51655-0733-52 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-733-52) | Nabumetone | Northwind Health Company, LLC | 2021-07-07 |
| 55700-0840-60 | 60 TABLET in 1 BOTTLE (55700-840-60) | Nabumetone | Quality Care Products, LLC | 2020-01-24 |
| 60760-0369-14 | 14 TABLET in 1 BOTTLE, PLASTIC (60760-369-14) | Nabumetone | St. Mary's Medical Park Pharmacy | 2019-10-10 |
| 60760-0369-60 | 60 TABLET in 1 BOTTLE, PLASTIC (60760-369-60) | Nabumetone | St. Mary's Medical Park Pharmacy | 2020-01-27 |
| 60760-0369-90 | 90 TABLET in 1 BOTTLE, PLASTIC (60760-369-90) | Nabumetone | St. Mary's Medical Park Pharmacy | 2021-02-23 |
| 62135-0145-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-145-60) | Nabumetone | Chartwell RX, LLC | 2023-01-18 |
| 62135-0146-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-146-60) | Nabumetone | Chartwell RX, LLC | 2023-01-18 |
| 63187-0307-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (63187-307-30) | Nabumetone | Proficient Rx LP | 2019-01-01 |
| 63629-8509-01 | 500 TABLET in 1 BOTTLE (63629-8509-1) | Nabumetone | Bryant Ranch Prepack | 2019-06-26 |
| 63629-8510-01 | 100 TABLET in 1 BOTTLE (63629-8510-1) | Nabumetone | Bryant Ranch Prepack | 2019-06-26 |
| 68788-7597-01 | 100 TABLET in 1 BOTTLE (68788-7597-1) | Nabumetone | Preferred Pharmaceuticals Inc. | 2020-02-13 |
| 68788-7597-02 | 20 TABLET in 1 BOTTLE (68788-7597-2) | Nabumetone | Preferred Pharmaceuticals Inc. | 2020-02-13 |
| 68788-7597-03 | 30 TABLET in 1 BOTTLE (68788-7597-3) | Nabumetone | Preferred Pharmaceuticals Inc. | 2020-02-13 |
| 68788-7597-06 | 60 TABLET in 1 BOTTLE (68788-7597-6) | Nabumetone | Preferred Pharmaceuticals Inc. | 2020-02-13 |
| 68788-7597-08 | 120 TABLET in 1 BOTTLE (68788-7597-8) | Nabumetone | Preferred Pharmaceuticals Inc. | 2020-02-13 |
| 68788-7597-09 | 90 TABLET in 1 BOTTLE (68788-7597-9) | Nabumetone | Preferred Pharmaceuticals Inc. | 2020-02-13 |
| 69097-0965-07 | 100 TABLET, FILM COATED in 1 BOTTLE (69097-965-07) | Nabumetone | Cipla USA Inc. | 2019-03-06 |
| 69097-0965-12 | 500 TABLET, FILM COATED in 1 BOTTLE (69097-965-12) | Nabumetone | Cipla USA Inc. | 2019-03-06 |
| 69097-0966-07 | 100 TABLET, FILM COATED in 1 BOTTLE (69097-966-07) | Nabumetone | Cipla USA Inc. | 2019-03-06 |
| 69097-0966-12 | 500 TABLET, FILM COATED in 1 BOTTLE (69097-966-12) | Nabumetone | Cipla USA Inc. | 2019-03-06 |
| 69367-0241-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69367-241-01) | Nabumetone | Westminster Pharmaceuticals, LLC | 2019-09-25 |
| 69367-0241-05 | 500 TABLET in 1 BOTTLE, PLASTIC (69367-241-05) | Nabumetone | Westminster Pharmaceuticals, LLC | 2019-09-25 |
| 69367-0242-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69367-242-01) | Nabumetone | Westminster Pharmaceuticals, LLC | 2019-09-25 |
| 69367-0242-05 | 500 TABLET in 1 BOTTLE, PLASTIC (69367-242-05) | Nabumetone | Westminster Pharmaceuticals, LLC | 2019-09-25 |
| 70518-4047-00 | 14 TABLET in 1 BOTTLE, PLASTIC (70518-4047-0) | Nabumetone | REMEDYREPACK INC. | 2024-04-07 |
| 70518-4047-01 | 60 TABLET in 1 BOTTLE, PLASTIC (70518-4047-1) | Nabumetone | REMEDYREPACK INC. | 2024-05-16 |
| 70518-4047-02 | 60 TABLET in 1 BOTTLE, PLASTIC (70518-4047-2) | Nabumetone | REMEDYREPACK INC. | 2026-02-23 |
| 71205-0530-30 | 30 TABLET in 1 BOTTLE (71205-530-30) | Nabumetone | Proficient Rx LP | 2021-02-03 |
| 71205-0530-60 | 60 TABLET in 1 BOTTLE (71205-530-60) | Nabumetone | Proficient Rx LP | 2021-02-03 |
| 71205-0530-90 | 90 TABLET in 1 BOTTLE (71205-530-90) | Nabumetone | Proficient Rx LP | 2021-02-03 |
| 71205-0977-00 | 100 TABLET in 1 BOTTLE, PLASTIC (71205-977-00) | Nabumetone | Proficient Rx LP | 2020-05-07 |
| 71205-0977-30 | 30 TABLET in 1 BOTTLE, PLASTIC (71205-977-30) | Nabumetone | Proficient Rx LP | 2020-05-07 |
| 71205-0977-55 | 500 TABLET in 1 BOTTLE, PLASTIC (71205-977-55) | Nabumetone | Proficient Rx LP | 2020-05-07 |
| 71205-0977-60 | 60 TABLET in 1 BOTTLE, PLASTIC (71205-977-60) | Nabumetone | Proficient Rx LP | 2020-05-07 |
| 71205-0977-72 | 120 TABLET in 1 BOTTLE, PLASTIC (71205-977-72) | Nabumetone | Proficient Rx LP | 2020-05-07 |
| 71205-0977-90 | 90 TABLET in 1 BOTTLE, PLASTIC (71205-977-90) | Nabumetone | Proficient Rx LP | 2020-05-07 |
Observed labelers:
Bryant Ranch Prepack (25) ·
Proficient Rx LP (16) ·
direct rx (7) ·
LGM PHARMA SOLUTIONS, LLC (7) ·
Preferred Pharmaceuticals Inc. (6) ·
ScieGen Pharmaceuticals Inc (6)
· +13 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.